HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1898645Generated: November 1, 2026
Water → 2-(2-chlorothiazol-5-yl)-5-(2-trimethylsilanyl-ethoxymethyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid [(R)-1-(4-cyano-piperidine-1-carbonyl)-2,2-dimethyl-propyl]-amide
https://huagongshe.com/reaction/1898645
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | Cesium carbonate | HCID 10796 | — |
| Reactant | 2-Chloro-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-thiazole | HCID 11601223 | — |
| Reactant | 2-bromo-5-(2-trimethylsilanyl-ethoxymethyl)-5H-pyrrolo[2,3-]pyrazine-7-carboxylic acid [(R)-1-(4-cyano-piperidine-1-carbonyl)-2,2-dimethyl-propyl]-amide | HCID 58438532 | — |
| Catalyst | Tetrakis(triphenylphosphine)palladium | HCID 11979704 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | 2-(2-chlorothiazol-5-yl)-5-(2-trimethylsilanyl-ethoxymethyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid [(R)-1-(4-cyano-piperidine-1-carbonyl)-2,2-dimethyl-propyl]-amide | HCID 67386019 | 36.6% |
Reaction Steps
In a microwave vial, 1,4-dioxane (3 mL) was purged with argon gas. 2-Bromo-5-(2-trimethylsilanyl-ethoxymethyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid [(R)-1-(4-cyano-piperidine-1-carbonyl)-2,2-dimethyl-propyl]-amide (100 mg, 0.173 mmol), 2-chloro-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-thiazole (128 mg, 0.519 mmol), palladium tetrakis(triphenylphosphine) (10 mg, 0.009 mmol), and then cesium carbonate (113 mg, 0.346 mmol) were added. The reaction vessel was sealed and heated in a microwave reactor at 170° C. for 1 h. Additional 2-chloro-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-thiazole (90 mg, 0.366 mmol) and palladium tetrakis(triphenylphosphine) (6 mg, 0.005 mmol) were added and the reaction was resubjected at 170° C. for 2 h. The reaction was cooled and water and ethyl acetate were added. The layers were separated and the aqueous layer was extracted twice more with ethyl acetate. The combined organic layers were washed with brine and dried over sodium sulfate. After evaporation, the residue was purified by silica gel chromatography (methanol/dichloromethane) to yield 39 mg (36%) of 2-(2-chlorothiazol-5-yl)-5-(2-trimethylsilanyl-ethoxymethyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid [(R)-1-(4-cyano-piperidine-1-carbonyl)-2,2-dimethyl-propyl]-amide. (M+Na)+=638.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08518945B2 |
|---|
| Source dataset | uspto-grants-2013_08 |
|---|
| ORD ID | ord-03fc87818d514e4c9977f69b865bdcf0 |
|---|
| Source note | uspto-grants-2013_08 |
|---|